Pharmacologically active peptides
AssigneeEli Lilly and Company
InventorsEdward L. Smithwick, Jr., Robert C. A. Frederickson, Robert T. Shuman
Life of this patent
Estimating the term…
Loading patent…
AssigneeEli Lilly and Company
InventorsEdward L. Smithwick, Jr., Robert C. A. Frederickson, Robert T. Shuman
Estimating the term…
Compounds of the formula ##STR1## and pharmaceutically acceptable non-toxic acid addition salts thereof, in which L and D define the chirality; R.sub.1 and R.sub.2 independently are hydrogen or C.sub.1 -C.sub.3 primary alkyl; R.sub.3 is C.sub.1 -C.sub.4 primary or secondary alkyl, C.sub.1 -C.sub.2 hydroxyalkyl, or --CH.sub.2 CH.sub.2 --U--CH.sub.3, in which U is O or S; R.sub.4 is C.sub.1 -C.sub.3 primary alkyl; Y is hydrogen or acetyl; Z is --CH.sub.2 OH or ##STR2## in which R.sub.5 is C.sub.1 -C.sub.3 alkyl or hydrogen; and W is isopropyl, --VR.sub.6, or --CH.sub.2 --X--CH.sub.3, in which V is O or S, R.sub.6 is C.sub.1 -C.sub.4 alkyl or aralkyl, and X is O, S, or CH.sub.2 --; are useful analgesic agents.
A compound of the formula ##STR10## and pharmaceutically acceptable non-toxic acid addition salts thereof, in which L and D define the chirality;
Dependencies are inferred from the claim text.